|This article relies too much on references to primary sources. (December 2010) (Learn how and when to remove this template message)|
Mondobiotech is a Swiss-based biotechnology company focused on developing human peptides as medicaments for patients affected by rare diseases.
Mondobiotech was founded in 2000 by Fabio Cavalli and Dorian Bevec. In March 2012, Pharma Times reported that mondoBIOTECH was “financially troubled” and was in exclusive negotiations with Pierrel Research, the contact research division of the Italian company Pierrel.
Research and development
Mondobiotech creates drugs for rare diseases.
- Winner of the Swiss Life Sciences Prize 2005.
- Selected Technology Pioneer 2008 by The World Economic Forum.
Notes and references
- Mansell, Peter (6 March 2012). "Pierrel in negotiations for mondoBIOTECH merger". Pharma Times. Retrieved 9 March 2015.